We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$33.6B
AUM Growth
+$1.17B
(+3.6%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
81
New
10
Increased
30
Reduced
38
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$378M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$222M |
| 3 |
Okta
OKTA
|
+$210M |
| 4 |
BLUE
bluebird bio
BLUE
|
+$148M |
| 5 |
Zoom
ZM
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$360M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$338M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$328M |
| 4 |
Shopify
SHOP
|
+$268M |
| 5 |
Atlassian
TEAM
|
+$64.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 20.96% |
| 3 | Healthcare | 20.88% |
| 4 | Communication Services | 16.1% |
| 5 | Financials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$697B
| $2.72B | 8.1% |
15,684,204
-213,073
| -1% | -$34.9M |
|
2
Amazon
AMZN
$2.48T
| $2.43B | 7.22% |
25,649,000
-656,480
| -2% | -$61.2M |
|
3
Alibaba
BABA
$276B
| $2.42B | 7.19% |
14,272,259
-72,842
| -0.5% | -$12.6M |
|
4
Netflix
NFLX
$301B
| $1.82B | 5.42% |
49,565,250
-1,262,720
| -2% | -$45.6M |
|
5
ServiceNow
NOW
$114B
| $1.67B | 4.98% |
30,498,005
-857,945
| -3% | -$45.1M |
|
6
Edwards Lifesciences
EW
$48.2B
| $1.39B | 4.12% |
22,504,224
-578,778
| -3% | -$35M |
|
7
Illumina
ILMN
$29.2B
| $1.33B | 3.97% |
3,727,051
-94,936
| -2% | -$30M |
|
8
Workday
WDAY
$39.4B
| $1.21B | 3.61% |
5,905,561
-158,834
| -3% | -$32.1M |
|
9
Alphabet (Google) Class A
GOOGL
$4.08T
| $1.19B | 3.55% |
22,054,760
-795,700
| -3% | -$46.1M |
|
10
Meta Platforms (Facebook)
META
$1.51T
| $1.13B | 3.36% |
5,844,160
-127,087
| -2% | -$23.2M |
|
11
Salesforce
CRM
$149B
| $1.12B | 3.33% |
7,373,836
-160,018
| -2% | -$25.1M |
|
12
Adobe
ADBE
$99B
| $1.04B | 3.09% |
3,520,239
+7,267
| +0.2% | +$2.02M |
|
13
Align Technology
ALGN
$12.6B
| $852M | 2.53% |
3,112,239
-79,863
| -3% | -$24.1M |
|
14
CoStar Group
CSGP
$12.4B
| $810M | 2.41% |
14,628,240
-399,910
| -3% | -$20.4M |
|
|
15
Atlassian
TEAM
$25.4B
| $755M | 2.25% |
5,768,868
-537,740
| -9% | -$64.8M |
|
16
Match Group
MTCH
$9.16B
| $658M | 1.96% |
9,788,897
-260,391
| -3% | -$17M |
|
17
Monster Beverage
MNST
$95.6B
| $652M | 1.94% |
20,435,190
-571,610
| -3% | -$17.2M |
|
18
ASML
ASML
$608B
| $646M | 1.92% |
3,104,998
-77,599
| -2% | -$15.4M |
|
19
Nike
NKE
$63.9B
| $612M | 1.82% |
7,288,022
-311,413
| -4% | -$26.2M |
|
20
Intuit
INTU
$85.6B
| $587M | 1.75% |
2,247,633
+35,728
| +2% | +$9.08M |
|
|
ABMD
21
DELISTED
Abiomed Inc
ABMD
| $557M | 1.66% |
2,136,426
+835,078
| +64% | +$222M |
|
22
Sarepta Therapeutics
SRPT
$1.63B
| $536M | 1.59% |
3,525,576
-91,518
| -3% | -$11.1M |
|
|
23
Shopify
SHOP
$169B
| $497M | 1.48% |
16,547,750
-10,308,660
| -38% | -$268M |
|
24
BioMarin Pharmaceuticals
BMRN
$12B
| $491M | 1.46% |
5,731,963
-149,483
| -3% | -$12.8M |
|
|
25
Zoetis
ZTS
$32.5B
| $444M | 1.32% |
3,915,215
+3,614,186
| +1,201% | +$378M |
|
Similar funds
KK
VAI
UIM
SO
Sands Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Sands Capital Management held 81 positions worth $33.6B, up 3.6% from $32.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sands Capital Management's Q2 2019 filing shows 10 new, 30 increased, 38 reduced and 2 closed positions. Its largest new stake was Okta: 1,938,689 shares worth $239M. The largest sale was Booking.com, an estimated $360M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sands Capital Management's largest Q2 2019 buy was Okta: 1,938,689 shares worth $239M.
- Sands Capital Management added most to Zoetis in Q2 2019, an estimated $378M increase.
- Sands Capital Management's biggest Q2 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $338M.
- Sands Capital Management fully exited Booking.com in Q2 2019, selling an estimated $360M.
- Sands Capital Management's ten largest holdings make up 52% of its $33.6B portfolio in Q2 2019.
- Sands Capital Management opened 10 new positions and closed 2 in Q2 2019.
- Sands Capital Management's portfolio value rose 3.6% quarter-over-quarter to $33.6B.
Based on Sands Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.